Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases

Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases The cases, observed mostly in young men who had received the Pfizer/BioNTech jab, have a ‘probable link’ to the second dose of the vaccine, according to Israel. ... Pfizer/BioNTech and Moderna’s are the only two mRNA-based vaccines approved for use

Moderna seeks full FDA approval for its COVID-19 vaccine

Moderna seeks full FDA approval for its COVID-19 vaccine year. Moderna’s mRNA-1273 vaccine became the second COVID-19 vaccine to be granted an FDA EUA, following Pfizer/BioNTech’s jab. ... Pfizer/BioNTech have also already filed their mRNA-based COVID-19 vaccine with the FDA for full approval, announcing

EMA authorises Pfizer/BioNTech’s COVID-19 vaccine for children aged 12 to 15

EMA authorises Pfizer/BioNTech’s COVID-19 vaccine for children aged 12 to 15 Pfizer and BioNTech’s mRNA-based COVID-19 vaccine has been approved for children aged 12 to 15 in the European Union (EU). ... The US Food and Drug Administration (FDA) has already expanded its emergency use authorisation (EUA) for the Pfizer/BioNTech

Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab

Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab Trial will enrol 600 adults, aged 65 and older, from the phase 3 Pfizer/BioNTech COVID-19 vaccine trial. ... 20vPnC includes capsular polysaccharide conjugates for the 13 serotypes in Pfizer’s licensed Prevnar 13 pneumococcal vaccine candidate.

AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant

AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant A UK study has found that two doses of either the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines are ‘highly effective’ against the recently identified Indian variant, B.1.617.2. ... Between 5 April and 16 May, researchers found that the

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...